Some in China return to regular activity after COVID infections
Few answers: the science on gender-care outcomes for youths
Vaccine hesitancy lingers even as China COVID cases surge
Africa’s worsening food crisis is the biggest yet
Factbox: China's approved COVID treatments
Pfizer sees $10 bln-$15 bln in potential revenue from mRNA vaccines by 2030